Suppr超能文献

在胰岛素抵抗的人群中,血浆胃饥饿素在空腹时水平较低,且不受胰岛素抑制。

Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans.

作者信息

Anderwald-Stadler Marietta, Krebs Michael, Promintzer Miriam, Mandl Martina, Bischof Martin G, Nowotny Peter, Kästenbauer Thomas, Luger Anton, Prager Rudolf, Anderwald Christian

机构信息

Third Medical Department of Metabolic Diseases and Nephrology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.

出版信息

Am J Physiol Endocrinol Metab. 2007 Nov;293(5):E1393-8. doi: 10.1152/ajpendo.00330.2007. Epub 2007 Sep 4.

Abstract

Obestatin, a recently discovered 23-amino acid peptide, is involved in the regulation of appetite and body weight in antagonistic fashion to ghrelin, both deriving from a common precursor peptide. Ghrelin was shown to be associated with insulin resistance, which may also affect obestatin. We investigated the association between insulin resistance and plasma concentrations of obestatin and ghrelin in nondiabetic individuals with high (IS; n = 18, 13 females and 5 males, age 47 +/- 2 yr, BMI = 25.5 +/- 0.9 kg/m(2)) and low (IR; n = 18, 12 females and 6 males, age 45 +/- 2 yr, P = 0.49, BMI = 27.5 +/- 1.1 kg/m(2), P = 0.17) insulin-stimulated glucose disposal (M), measured by 2-h hyperinsulinemic (40 mU.min(-1).m(-2)) isoglycemic clamp tests. M(100-120 min) was higher in IS (10.7 +/- 0.7) than in IR (4.4 +/- 0.2 mg.min(-1).kg(-1), P < 10(-9)), whereas insulin-dependent suppression of free fatty acids (FFA) in plasma was reduced in IR (71 +/- 6% vs. IS: 82 +/- 5%, P < 0.02). In both groups, plasma ghrelin concentrations were comparable at fasting and similarly reduced by 24-28% during insulin infusion. IR had lower fasting plasma obestatin levels (383 +/- 26 pg/ml vs. IS: 469 +/- 23 pg/ml, P < 0.02). Clamp insulin infusion reduced plasma obestatin to approximately 81% of basal values in IS (P < 0.00002), but not in IR. Fasting plasma obestatin was correlated positively with M (r = 0.34, P = 0.04), HDL cholesterol (r = 0.45, P = 0.01), and plasma ghrelin concentrations (r = 0.80, P < 0.000001) and negatively with measures of adiposity, plasma FFA during clamp (r = -0.42, P < 0.01), and systolic blood pressure (r = -0.33, P < 0.05). In conclusion, fasting plasma concentrations of obestatin, but not of ghrelin, are reduced in insulin resistance and are positively associated with whole body insulin sensitivity in nondiabetic humans. Furthermore, plasma obestatin is reduced by insulin in insulin-sensitive but not in insulin-resistant persons.

摘要

肥胖抑制素是一种最近发现的含23个氨基酸的肽,它以与胃饥饿素相反的方式参与食欲和体重的调节,二者都来源于一个共同的前体肽。胃饥饿素已被证明与胰岛素抵抗有关,这也可能影响肥胖抑制素。我们研究了非糖尿病个体中胰岛素抵抗与肥胖抑制素和胃饥饿素血浆浓度之间的关系,这些个体具有高(IS;n = 18,13名女性和5名男性,年龄47±2岁,BMI = 25.5±0.9 kg/m²)和低(IR;n = 18,12名女性和6名男性,年龄45±2岁,P = 0.49,BMI = 27.5±1.1 kg/m²,P = 0.17)胰岛素刺激的葡萄糖处置(M),通过2小时高胰岛素血症(40 mU·min⁻¹·m⁻²)等血糖钳夹试验测量。IS组中M(100 - 120分钟)(10.7±0.7)高于IR组(4.4±0.2 mg·min⁻¹·kg⁻¹,P < 10⁻⁹),而IR组中血浆游离脂肪酸(FFA)的胰岛素依赖性抑制降低(71±6%对IS组:82±5%,P < 0.02)。在两组中,空腹时血浆胃饥饿素浓度相当,并且在胰岛素输注期间同样降低24 - 28%。IR组空腹血浆肥胖抑制素水平较低(383±26 pg/ml对IS组:469±23 pg/ml,P < 0.02)。钳夹胰岛素输注使IS组血浆肥胖抑制素降低至基础值的约81%(P < 0.00002),但IR组未降低。空腹血浆肥胖抑制素与M呈正相关(r = 0.34,P = 0.04)、与高密度脂蛋白胆固醇呈正相关(r = 0.45,P = 0.01)、与血浆胃饥饿素浓度呈正相关(r = 0.80,P < 0.000001),与肥胖指标、钳夹期间血浆FFA呈负相关(r = -0.42,P < 0.01)以及与收缩压呈负相关(r = -0.33,P < 0.05)。总之,在胰岛素抵抗患者中,空腹血浆肥胖抑制素浓度降低,而胃饥饿素浓度未降低,并且在非糖尿病个体中,空腹血浆肥胖抑制素浓度与全身胰岛素敏感性呈正相关。此外,胰岛素敏感者的血浆肥胖抑制素会被胰岛素降低,而胰岛素抵抗者则不会。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验